NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 263 filers reported holding NEOGENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $387,475 | -7.2% | 31,506 | +21.3% | 0.00% | 0.0% |
| Q2 2023 | $417,498 | -49.5% | 25,977 | -45.3% | 0.00% | -50.0% |
| Q1 2023 | $826,400 | +336.5% | 47,482 | +130.1% | 0.00% | – |
| Q4 2022 | $189,310 | -4.9% | 20,636 | -11.2% | 0.00% | – |
| Q3 2022 | $199,000 | -1.0% | 23,228 | -6.4% | 0.00% | – |
| Q2 2022 | $201,000 | -81.1% | 24,810 | +24.9% | 0.00% | -100.0% |
| Q1 2022 | $1,066,000 | +37.4% | 19,869 | -12.7% | 0.00% | +100.0% |
| Q4 2021 | $776,000 | -35.8% | 22,750 | -9.2% | 0.00% | -66.7% |
| Q3 2021 | $1,208,000 | -6.6% | 25,048 | -12.6% | 0.00% | 0.0% |
| Q2 2021 | $1,294,000 | +28.0% | 28,669 | +36.7% | 0.00% | +50.0% |
| Q1 2021 | $1,011,000 | -66.5% | 20,975 | -62.6% | 0.00% | -75.0% |
| Q4 2020 | $3,016,000 | +24.1% | 56,025 | -24.4% | 0.01% | +14.3% |
| Q3 2020 | $2,430,000 | -2.8% | 74,070 | -8.2% | 0.01% | -12.5% |
| Q2 2020 | $2,501,000 | -4.2% | 80,668 | -17.1% | 0.01% | -27.3% |
| Q1 2020 | $2,611,000 | – | 97,279 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,612,363 | $55,014,000 | 24.06% |
| PERKINS CAPITAL MANAGEMENT INC | 155,550 | $5,307,000 | 3.58% |
| First Light Asset Management, LLC | 763,907 | $26,065,000 | 1.87% |
| Bullseye Asset Management LLC | 108,054 | $3,617,000 | 1.44% |
| Ranger Investment Management | 756,380 | $25,808,000 | 1.41% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,006,088 | $34,328,000 | 1.21% |
| EMERALD ADVISERS, LLC | 885,436 | $30,211,000 | 1.12% |
| Granite Investment Partners, LLC | 963,187 | $32,864,000 | 0.96% |
| Nicholas Investment Partners, LP | 428,378 | $14,616,000 | 0.92% |
| Redwood Investments, LLC | 335,054 | $11,432,000 | 0.90% |